Navigation Links
Inverness Medical Innovations Announces September Investor Conference Schedule
Date:9/10/2009

WALTHAM, Mass., Sept. 10 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (NYSE: IMA), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it will attend several healthcare industry investor conferences during the month of September.

  • Ron Zwanziger, Chief Executive Officer, and Jon Russell, Vice President, Finance, will attend the Morgan Stanley Global Healthcare Conference being held on September 14 and 15, 2009 at the Grand Hyatt New York, Park Avenue at Grand Central. Mr. Zwanziger's presentation is scheduled for Monday, September 14, 2009 at 2:45 p.m., and will be made available to the public through a webcast accessible through the company's website at http://www.invmed.com/investors.cfm and the Morgan Stanley Conference website at http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=IMA&item_id=2400719.
  • Mr. Zwanziger and Mr. Russell will attend the Stifel Nicolaus/Johns Hopkins Annual Healthcare Symposium being held at the Hilton, Baltimore, Maryland on Tuesday, September 15, 2009. This symposium will not be webcast.
  • Mr. Russell will attend ThinkEquity's 6(th) Annual Growth Conference being held at the St. Regis, San Francisco on Wednesday, September 16. Mr. Russell's presentation is scheduled for 9:30 a.m., and will not be webcast.
  • Mr. Zwanziger and Mr. Russell will attend the UBS Global Life Sciences Conference being held on September 21 through the 23, 2009 at the Grand Hyatt New York, Park Avenue at Grand Central. Mr. Zwanziger's presentation is scheduled for Tuesday, September 22, 2009 at 11:30 a.m. and will be made available to the public through a webcast accessible through the company's website at http://www.invmed.com/investors.cfm and the UBS Conference website at http://cc.talkpoint.com/ubsx001/092109a_ke/?entity=143_EFSBJ3O.

During their presentations, Mr. Zwanziger and Mr. Russell may discuss and answer questions concerning business and financial developments and trends. Their responses to questions, as well as other matters discussed during the webcasts, may contain or constitute information that has not been disclosed previously. Replays of the webcasts will be available via the links indicated above for 30 days.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts.


'/>"/>
SOURCE Inverness Medical Innovations, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
2. Inverness Medical Innovations to Present at the Canaccord Adams Global Growth Conference on August 11, 2009
3. Inverness Medical Innovations, Inc. Announces Offering of $150 Million of Senior Notes
4. CVS Caremark and Inverness Medical Innovations Launch Strategic Alliance to Provide Enhanced Health Management Services to Clients
5. Inverness Medical Innovations Announces Second Quarter 2009 Results
6. Inverness Medical Innovations Proposes to Acquire Concateno plc
7. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
8. Inverness Medical Innovations to Present at the Deutsche Bank 34th Annual Health Care Conference on May 19, 2009
9. Inverness Medical Innovations to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference on May 12, 2009
10. Inverness Medical Innovations, Inc. Announces Offering of $200 Million of Senior Subordinated Notes
11. Inverness Medical Innovations Announces First Quarter 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/22/2017)... , ... April 22, 2017 ... ... of Eastern Pennsylvania has named PROSHRED® Security of Philadelphia its “Woman-Owned ... PROSHRED® Philadelphia specializes in providing information destruction , recycling, and ...
(Date:4/22/2017)... (PRWEB) , ... April 22, 2017 , ... ... to his role as Vice President of Sales and Business Development at OAKWORKS, ... GPO/IDN business partner engagements, business development, and strategic planning for the company. ...
(Date:4/21/2017)... , ... April 21, 2017 , ... An April 10 ... a pair of ancient teeth, which reveal a great deal about prehistoric ice-age dental ... sharp stone may have been used to remove decayed dental matter, and that teeth ...
(Date:4/21/2017)... Beach, FL (PRWEB) , ... April 21, 2017 , ... The staff at Palm Beach ... will be taking part in the 2017 London Marathon. Set to take place on April ... charitable organizations. This year, Dr. Schwartz will run as part of team EMPOWER, raising money ...
(Date:4/21/2017)... ... 2017 , ... Chicago plastic surgeon, Dr. Anil R. Shah, MD , ... benign bony lump located on the forehead usually attributed to a facial fracture. Their ... pain. Dr. Shah has discovered an approach that is minimally invasive. He is an ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
(Date:4/20/2017)... April 20, 2017 Eyevensys, a ... first non-viral gene expression technology that enables the safe, ... to address a wide range of ophthalmic diseases, announces ... Healthcare products Regulatory Agency (MHRA) to advance its technology ... ...
(Date:4/20/2017)... , April 20, 2017 Research and ... Pharmaceutical Contract Manufacturing Services Market Analysis By Service (Manufacturing, Research), ... Forecasts, 2014 - 2025" report to their offering. ... The Latin American pharmaceutical ... billion by 2025 Low drug registration cost in ...
Breaking Medicine Technology: